Search clinical trials for: Nepafenac

Total 53 results

Alcon Research

Completed

Confirmatory Study Nepafenac 0.3%

Cataract

United States
Jaeb Center for Health Research
National Eye Institute (NEI)

Completed

NSAID Phase II for Non-central Involved Diabetic Macular Edema (DME)

Diabetic Macular Edema

United States
Alcon Research

Completed

Nepafenac 0.3% Two Study

Cataract

United States
Actavis Inc.

Completed

Clinical Endpoint Study of Nepafenac 0.3% Opthalmic Suspension

Cataract

United States
Alcon Research

Terminated

Macular Edema Incidence/Severity Reduction With Nevanac

Diabetic Retinopathy

United States
Alcon Research

Completed

Nepafenac Compared to Placebo for Ocular Pain and Inflammation

Cataract

China
Melissa Toyos
Bausch & Lomb Incorporated

Completed

Prolensa (Bromfenac) 0.07% QD vs. Ilevro (Nepafenac) 0.3% QD for Treatment of Ocular Inflammation Post Cataract Surgery (QD)

Inflammation | Cataract | Retinal Edema

United States
Alcon Research

Completed

Role of Nepafenac in Reducing Macular Volume After Epiretinal Membrane Surgery

Epiretinal Membrane

United States
Intuor Technologies, Inc.

Completed

Prospective Study With Adjunctive Once Daily Topical Nepafenac 0.3% Versus Placebo

Cystoid Macular Edema
Universiti Sains Malaysia

Completed

Topical Nepafenac as Supplement for Diabetic Macular Edema

Diabetic Macular Edema

Malaysia
Dr T V Patel Eye Institute

Completed

Effect of Nepafenac Eye Drops on Intraocular Pressure in Normal Eyes

Intraocular Pressure

India
Alcon Research

Completed

Nepafenac Opthalmic Suspension 0.1% Compared to Acular LS for Treatment of Inflammation After Cataract Surgery

Cataract

United States
University Hospital of Patras

Completed

Comparison of the Efficacy of Nepafenac 0.1% and Nepafenac 0.3 % on Pain Associated With Intravitreal Injections

Pain

Greece
Mati Therapeutics Inc.

Completed

Safety/Efficacy of Nepafenac Punctal Plug Delivery System Compared to Placebo to Control Ocular Pain/Inflammation After Cataract

Pain | Inflammation

United States
University of North Carolina, Chapel Hill
Research to Prevent Blindness

Completed

Effect of Nepafenac on Post-operative Macular Swelling Following Uncomplicated Cataract Surgery

Cystoid Macular Edema

United States
Alcon Research

Completed

Nevanac 3-Month Safety Study With QID Dosing

Cataract

United States
Center For Excellence In Eye Care
Allergan

Completed

Comparison of Acular LS Versus Nevanac for Pain Control in Eyes Undergoing PRK

Myopia | Hyperopia
Bp Consulting, Inc

Completed

Evaluation of Comfort With Xibrom (Bromfenac Ophthalmic Solution)0.09% and Nevanac (Nepafenac Ophthalmic Suspension) 0.1% Following Selective Laser Trabeculoplasty (SLT)

Intraocular Pressure

United States
Federal University of São Paulo

Completed

Efficacy Study of Triamcinolone Associated With Nepafenac for Treatment of Diabetic Macular Edema (NEVANAC)

Diabetic Macular Edema

Brazil
Alcon Research

Completed

Nepafenac 0.1% Eye Drops, Suspension Compared to Ketorolac Trometamol 0.5% Eye Drops, Solution and Placebo

Cataracts

France
Alcon Research
Matthew Caldwell

Completed

A Comparison of Topical Nepafenac to Placebo in Corneal Epithelial Healing Times and Postoperative Pain Relief

Photorefractive Keratectomy

United States
MDbackline, LLC
Alcon Research

Completed

Tolerability and Toxicity of Topically Applied Nepafenac 0.3% vs Ketorolac 0.5%

Cataract

United States
Oslo University Hospital

Recruiting

Cataract Surgery and Inflammation - the Role for Preoperative NSAIDs (Pre-CIN) (pre-CIN)

Cataract Surgery

Norway
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Prostaglandin E2 (PGE2) Inhibition of Acuvail(Ketorolac 0.45%), Xibrom (Bromfenac 0.09%)and Nevanac (Nepafenac)in Patients Undergoing Phacoemulsification

Cataracts
Oslo University Hospital

Recruiting

DSAEK/DMEK and Cystoid Macular Edema - the Role for Topical NSAIDs (Nepafenac) (DMEC) (DMEC)

Descemet Stripping Automated Endothelial Keratoplasty (DSAEK) | Descemet Membrane Endothelial Keratoplasty (DMEK)

Norway
Toyos Clinic
Bausch & Lomb Incorporated

Completed

Clinical Outcomes of Bromday (Bromfenac Ophthalmic Solution) 0.09% QD vs. Nevanac (Nepafenac Ophthalmic Suspension) 0.1%

Inflammation | Pseudophakia
Innovative Medical

Completed

Acular LS vs. Nevanac in Post op Inflammation Following Cataract Surgery

Cataract

United States
Alcon Research

Completed

Nepafenac Once Daily for Macular Edema - Study 1

Cataract | Non-Proliferative Diabetic Retinopathy
Queen's University

Completed

Prophylactic Nepafenac and Ketorolac Versus Placebo in Patients Undergoing Cataract Surgery (PNK)

Macular Edema

Canada
Alcon Research

Completed

Nepafenac Once Daily for Macular Edema - Study 2

Cataract | Non-Proliferative Diabetic Retinopathy
University Hospital of Patras

Completed

Effect of Topical Nepafenac 0.1% on Pain Related to Intravitreal Injections

Pain

Greece
Alcon Research

Completed

A Clinical Safety and Efficacy Comparison of NEVANAC 0.1% to Vehicle After Cataract Surgery in Diabetic Retinopathy Patients

Macular Edema
The New York Eye & Ear Infirmary

Unknown

Post Intravitreal Injection Topical NSAID vs. Patching

Diabetic Macular Edema | Retinal Vein Occlusion | Neovascular Age-related Macular Degeneration

United States
Frank A. Bucci, Jr., M.D.
Allergan

Completed

A Comparison of Peak Aqueous Penetration of Acuvail (Ketorolac 0.45%), Xibrom (Bromfenac 0.09%), and Nevanac (Nepafenac 0.1%)in Patients Undergoing Phacoemulsification

Cataracts

United States
L.V. Prasad Eye Institute
Allergan

Recruiting

CHED - Congenital Hereditary Endothelial Dystrophy: New Paradigm Shift in Therapy Using Topical Eye Drops

Congenital Hereditary Endothelial Dystrophy of Cornea

India
Assiut University

Unknown

Nepafenac Versus Ketorolac Eye Drops in Prevention of Intraoperative Miosis During Cataract Surgery

Cataract | Miosis
Sheba Medical Center

Unknown

Efficacy and Necessity of Anti-inflammatory Drops After Laser Peripheral Iridotomy

Glaucoma, Angle-Closure | Glaucoma, Closed-Angle | Glaucoma, Narrow-Angle

Israel
Santa Casa de Misericordia de Santos

Unknown

Comparison of Pain Sensation During Single Use of Two Topical Non-Steroidal Anti-Inflammatory Drugs (NSAIDs)

Pain

Brazil
Università degli Studi di Brescia

Completed

NSAIDs and PGE2 Levels in Vitrectomy Patients

Vitreous Inflammation
Dar El Oyoun Hospital

Completed

Eplerenone, Aflibercept and Topical Nepafenac Serous Foveal Deta Chment in Central Serous Chorioretinopathy (CSCR)

Central Serous Chorioretinopathy

Egypt
Silverstein Eye Centers
Bausch & Lomb Incorporated; Churchhill Communications; Statistics & Data Corporation

Completed

Study Title: Clinical Outcomes of Prolensa (Bromfenac Ophthalmic Solution) 0.07% QD vs. Ilevro (Nepafenac Ophthalmic Suspension) 0.3% QD With Extra (Pulse) Dose on Day of Surgery for Treatment of Ocular Inflammation Associated With Cataract Surgery in a Randomized, Single Masked Clinical Trial

Treatment of Ocular Inflammation Associated With Cataract Surgery
Laboratorios Sophia S.A de C.V.

Completed

Efficacy and Safety of PRO-155 Versus Nevanac in Post Phacoemulsification

Cataract | Phacoemulsification Cataract Surgery

Mexico
Asociación para Evitar la Ceguera en México

Unknown

Effect of Topical Nepafenac in Macular Thickening Related to Pan-Retinal Photocoagulation (NEPAF)

Macular Edema | Macular Thickening

Mexico
University of Trieste

Completed

PGE2 Levels in Patient Treated With NSAIDs

Ocular Inflammation

Italy
Clinica Oftamologica Zona Sul

Unknown

Effect of Anti-inflammatory Topical Prednisolone, Nepafenac and Ketorolac in Intra-operative Mydriasis in Facetectomies

Cataract

Brazil
University of California, Los Angeles
National Institute on Drug Abuse (NIDA)

Completed

Trial of Ibudilast for Methamphetamine Dependence (IBUD ph II)

HIV Infection | Methamphetamine Dependence

United States
Wolfson Medical Center

Unknown

Comparison of Diclofenac vs. Nepafenac Ophthalmic Drops: Patient Comfort

Pain Management | Post Surgical Management | Inflamation Management

Israel
Hospital Oftalmologico de Brasilia

Completed

Anti-inflammatory Efficacy for Prophylaxis of Cystoid Macular Edema (CME) After Phacoemulsification

Cataract | Cystoid Macular Edema

Brazil
Innovative Medical

Completed

Comparison of Vitreous Levels of Acular LS 0.04%, Xibrom 0.09%, and Nevanac 0.1%

Vitrectomy

United States
Carolina Eyecare Physicians, LLC
Science in Vision

Completed

Dropless vs. Standard Drops Contralateral Eye Study

Cataract

United States

3

Subscribe